8 months on fin and 4 months on minox 5/4/2025
The user experienced significant hair regrowth using 1mg oral finasteride daily and a walnut-sized amount of minoxidil foam once a day. They started balding at 17 and reported no side effects from the treatments.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 5 months topical minoxidil and 1 mg oral fin, identical hair lengths.
A 25-year-old shared impressive hair regrowth results after 5 months using 5% topical minoxidil (Rogaine and Kirkland) and 1 mg oral finasteride (Propecia), with no shedding or side effects. The user applies minoxidil twice daily and finasteride once daily.
community This is not a cure. This is a miracle. Propecia and Minoxidil are not air, they are a very powerful force. 1 mg fin 2 a day Minoxidil- 17 Months
A user shared their successful hair regrowth experience using 1 mg oral finasteride daily and topical minoxidil twice a day for 17 months, along with microneedling and Ketosol shampoo. They reported significant hair density improvement without side effects, attributing their results to consistency and being a good responder to the treatment.
community M24 Minoxidil + Finasteride 4 Months Progress
A user shared their 4-month progress using minoxidil foam twice daily and 1 mg finasteride tablets, showing significant hair growth. The user reported no side effects from finasteride and used Propecia, the only available brand in their region.
community 9 months of progress. Propecia and minoxidil.
A user shared their 9-month progress using Propecia and minoxidil for hair loss, noting significant daily shedding. Others suggested potential vitamin/mineral deficiencies and offered encouragement.
community 16 months. Just a tough roller coaster. But the pictures speak for themselves. Propecia 1 mg topical minoxidil twice a day
The user experienced significant hair regrowth using Propecia (finasteride) 1 mg and topical minoxidil twice a day over 16 months, despite initial shedding. The user no longer needs a hair transplant and reports no side effects from the treatment.
community Questions about Topical Finasteride and more
The conversation discusses using topical finasteride (0.25% gel) and minoxidil (5% foam) for hair loss, with users sharing experiences about application methods, microneedling, and results. Some users have switched to oral finasteride for convenience and cost-effectiveness, while others discuss the greasy nature of the topical solution.
Related Research
6 / 6 results
research Optimal use of topical minoxidil in management of female pattern hair loss in India: an expert opinion
The authors provide an overview of using topical minoxidil to manage female pattern hair loss in Indian clinical practice, emphasizing its significance as the main treatment method.
research HAIR LOSS AND REGENERATION PERFORMED ON ANIMAL MODELS
This article reviews current research on animal models for hair regrowth treatments and reports no new findings; it highlights the need for studies comparing therapy efficiency and long-term safety.
research Androgenetic Alopecia
Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.
research Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
This study found that a topical combination of 0.25% finasteride and 3% minoxidil may increase hair diameter more effectively than 3% minoxidil alone in postmenopausal women with female pattern hair loss.
research Advances in Hair Diseases
This review discusses advancements in understanding hair cycle and inflammatory alopecias, proposing a standard classification and tiered treatment recommendations, but reports no clinical results.
research Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
This study reported that while no effective treatment exists for frontal fibrosing alopecia, oral 5-alpha-reductase inhibitors showed the most promise, inducing a good clinical response in 45% of patients.